Raphael Twerenbold, MD
@RTwerenbold
Followers
505
Following
341
Media
22
Statuses
212
Full-Professor of Cardiology | Interventional Cardiologist | Clinical Researcher | Enthusiast of Cardiovascular Biomarkers and Genomics | Medtech entrepreneur
Hamburg, Germany
Joined February 2017
🚨Brand new evidence from our global consortium GCVRC quantifying the lifetime-risk for CVD and death by 5️⃣ cvRF and the benefit associated with their modification, just published in @NEJM ❤️🩹🌍#ACC25.
Presented at #ACC25: . Using data from 2,078,948 participants from 39 countries, researchers calculated lifetime estimates of cardiovascular disease and death from any cause according to the presence or absence of cardiovascular risk factors. Full study results:
1
4
13
Safe rule-out of myocardial infarction possible in less than 10 minutes with @ACS_Pathfinder using ML-approaches. 💚or💔❓.Thanks to @BILD for their coverage on our study results presented by @BetuelToprak from @UKEHamburg @ESCCongress in London.
bild.de
Dank eines neuen Tests sollen Mediziner jetzt deutlich schneller erkennen, ob wirklich ein Herzinfarkt vorliegt.
2
1
9
Because we firmly believe that AI can support clinicians in their evidence-based decision making and thereby improve acute patient care. ❤️🩹🚑❓.Many thanks to @20min 🇨🇭for their report on the latest research from @UKEHamburg on our @ACS_Pathfinder .
20min.ch
Mit einem neuen Schnelltest, der mit KI funktioniert, können Ärzte Herzinfarkte schneller diagnostizieren oder ausschliessen.
1
1
4
🚨 Machine-learning algorithm for the rapid and safe triage of patients with suspected myocardial infarction. New data from @BetuelToprak et al from @UKEHamburg. Let‘s personalize patient care in the ED with @ACS_Pathfinder ❤️.
Forschende des #UKEHamburg konnten nachweisen, dass ein Herzinfarkt mittels KI-unterstützten Schnelltests noch schneller und effizienter als bislang ausgeschlossen werden kann. Studienergebnisse wurden heute im Lancet Digital Health veröffentlicht.
0
3
7
Another great study indicating the clinical utility of high-sensitivity entering the point-of-care troponin test arena. 🚨🚑❤️🩹Congrats to @luca_koechlin, @J_Boeddinghaus, @LopezAyalaP, @mrubini and team!.
jacc.org
0
4
10
RT @DGK_org: Heute ist der erste #BILDHerzgipfel in Berlin. Herzmediziner aus ganz Deutschland kommen zusammen, um über Prävention von Herz….
0
8
0
Gratulation an @MoritzSeiffert und alle Beteiligten für die erfolgreiche Durchführung dieser wegweisenden Studie, welche komplett industrie-unabhängig durch die @dzhk_germany und @Herzstiftung gefördert wurde. 👏.
Forschende des #UKEHamburg zeigen: Die kathetergestützte Therapie der Aortenklappenstenose ist dem operativen Klappenersatz auch bei jüngeren Patient:innen mit niedrigem und mittlerem Operationsrisiko ebenbürtig. Mehr Infos:
0
2
18
🚨Most excited about the results of our industry-independent DEDICATE trial presented by @MoritzSeiffert at #ACC24 and @NEJM, impressively demonstrating non-inferior safety of #TAVI versus #SAVR in lower risk patients. ❤️🩹@dzhk_germany @UCCS_HH @UKEHamburg.
nejm.org
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack...
0
6
30
Still looking for New Year's resolutions? Time to recap the results of our recent study @NEJM on the individual and global impact of 5 modifiable cardiovascular risk factors.🫀🩺🚬🍰 Happy and healthy 2024! @UKEHamburg @UCCS_HH .
nejm.org
Quick Take Video Summary from The New England Journal of Medicine — Modifiable Risk Factors, Cardiovascular Disease, and Mortality
0
3
15
Vaccination against arterial hypertension? 💉 Exciting data on a new therapeutic concept to control cardiovascular risk factors beyond lipids. ❤️
nejm.org
Angiotensinogen is the sole precursor of angiotensin peptides and has a key role in the pathogenesis of hypertension. Zilebesiran, an investigational RNA interference therapeutic agent with a prolo...
0
1
2
RT @JeanetteErdmann: Jetzt online: Abenteuer Diagnose #59 "Die Forscherin und das Geheimnis der Zebrafische" ist in der ARD Audiothek, auf….
0
9
0
More than sad to lose our colleague and friend Prof. Jeanette Erdmann: one of THE German pioneers in cardiogenetics! 🖤 Her unlimited enthusiasm for unravelling the role of genetics in cardiovascular health will live on in so many of us. ❤️🩹🧬.
Wir sind zutiefst betroffen und traurig: DZHK-Professorin Jeanette Erdmann ist am 8. Juli 2023 plötzlich verstorben. Sie war eine fabelhafte Wissenschaftlerin und ein wundervoller Mensch. Unser Mitgefühl gilt den Angehörigen. Wir werden sie nie vergessen. 🖤.
0
1
6
RT @HamburgBeats: Runde 1 im Boxring 🥊 bei den @HamburgBeats. Blaue Ecke: Christian Veltmann.Rote Ecke: Christina Magnussen. Gefightet wird….
0
11
0
🚨 Just published: a machine-learning approach to safely identify or exclude MI more efficiently, flexibly and individually than current standard of care. ❤️🩹? =👩🏼⚕️🩺🧪📲 = 🆘 or ✅. Thanks to the whole research consortium.
0
1
13
Congrats @mrubini ! 🫀👏🏻 Proud to see your story of success. Putting young professionals at the heart of the cardiovascular community: Maria Rubini Gimenez, MD @mrubini.
academic.oup.com
All correspondence relating to this article should be sent [email protected]
0
0
15
Very pleased with today‘s election of our medical director Stefan Blankenberg from the UHZ @UKEHamburg as the next president of the German Society of Cardiology.🫀 🎉👏🏻.
Die Mitgliederversammlung der DGK hat heute den Präsidenten der Gesellschaft für die Amtsperiode 2025-2027 gewählt: Herzlichen Glückwunsch, Prof. Dr. Stefan Blankenberg (Hamburg).Mehr Infos:
0
2
22
Exciting data on paradoxical effect of smoking 🚬on troponin in pts. with suspected MI ❤️🩹presented by @BetuelToprak from @UCCS_HH 🤗🚨#DGKJahrestagung @johannesneuman @Nils_Soensen
0
2
17
Proud to see @JonasLehmacher from @UCCS_HH presenting data on the additive prognostic utility of biomarkers beyond traditional risk factors in the young investigator award session. #DGKJahrestagung
0
4
21
New RCT on the utility of non-sensitive POC troponin testing in the pre-hospital triage of MI, suggesting high-safety in very low-risk patients. ❤️🩹🚑 Impact and applicability is expected to be even greater when using high-sensitivity POC tests.
Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial. Discover more in #EHJ. @escardio @ESC_Journals #CardioTwitter #biomarkers #acutecoronarysyndrome.
0
2
5